Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Lugli

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2007
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiologyAlessandro Lugli, Inti Zlobec, Gad Singer, et al.
BMC Gastroenterology|June 17, 2010
Role of tumor size in the pre-operative management of rectal cancer patientsInti Zlobec, Parham Minoo, Eva Karamitopoulou, et al.
Journal of Clinical Pathology|May 16, 2006
Construction and validation of a bone marrow tissue microarrayAnnette Zimpfer, Sharon Schönberg, Alessandro Lugli, et al.
Human Pathology|July 27, 2006
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approachAlessandro Lugli, Inti Zlobec, Parham Minoo, et al.
American Journal of Clinical Pathology|April 19, 2007
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancerParham Minoo, Inti Zlobec, Kristi Baker, et al.
Oncotarget|February 12, 2015
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinomaMartin Wartenberg, Inti Zlobec, Aurel Perren, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2021
Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancerHuu-Giao Nguyen, Oxana Lundström, Annika Blank, et al.
Journal of Translational Medicine|October 24, 2017
World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016Jerome Galon, Alessandro Lugli, Carlo Bifulco, et al.
Frontiers in Oncology|October 17, 2013
Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal CancerHeather Dawson, Viktor H Koelzer, Anne C Lukesch, et al.
Human Pathology|February 23, 2019
Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stromaSara N Meyer, José A Galván, Stefan Zahnd, et al.
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2007
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiologyAlessandro Lugli, Inti Zlobec, Gad Singer, et al.
BMC Gastroenterology|June 17, 2010
Role of tumor size in the pre-operative management of rectal cancer patientsInti Zlobec, Parham Minoo, Eva Karamitopoulou, et al.
Journal of Clinical Pathology|May 16, 2006
Construction and validation of a bone marrow tissue microarrayAnnette Zimpfer, Sharon Schönberg, Alessandro Lugli, et al.
Human Pathology|July 27, 2006
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approachAlessandro Lugli, Inti Zlobec, Parham Minoo, et al.
American Journal of Clinical Pathology|April 19, 2007
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancerParham Minoo, Inti Zlobec, Kristi Baker, et al.
Oncotarget|February 12, 2015
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinomaMartin Wartenberg, Inti Zlobec, Aurel Perren, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2021
Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancerHuu-Giao Nguyen, Oxana Lundström, Annika Blank, et al.
Journal of Translational Medicine|October 24, 2017
World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016Jerome Galon, Alessandro Lugli, Carlo Bifulco, et al.
Frontiers in Oncology|October 17, 2013
Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal CancerHeather Dawson, Viktor H Koelzer, Anne C Lukesch, et al.
Human Pathology|February 23, 2019
Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stromaSara N Meyer, José A Galván, Stefan Zahnd, et al.
Pageof 19